A systematic review of persistence and compliance with bisphosphonates for osteoporosis.
about
Carpal Tunnel Syndrome Associated with Oral Bisphosphonates. A Population-Based Cohort StudyProtocol for the Osteoporosis Choice trial. A pilot randomized trial of a decision aid in primary care practiceAdherence to osteoporosis pharmacotherapy is underestimated using days supply values in electronic pharmacy claims data.Compliance and persistence with daily, weekly, and monthly bisphosphonates for osteoporosis in Japan: analysis of data from the CISAThe association between compliance and persistence with bisphosphonate therapy and fracture risk: a reviewMeasuring patient perceptions about osteoporosis pharmacotherapy.Implementing adherence to osteoporosis treatments.Oral bisphosphonates and the risk of Barrett's esophagus: case-control analysis of US veterans.Knowledge on osteoporosis of prescriber according to level of medical instituteEfficacy and safety of zoledronic acid in the treatment of glucocorticoid-induced osteoporosis.Long-term administration of quarterly IV ibandronate is effective and well tolerated in postmenopausal osteoporosis: 5-year data from the DIVA study long-term extension.Development of clinical utility of zoledronic acid and patient considerations in the treatment of osteoporosisA blinded randomized controlled trial of motivational interviewing to improve adherence with osteoporosis medications: design of the OPTIMA trial.Challenges in implementing and maintaining osteoporosis therapy.Data from extension trials: denosumab and zoledronic acid.Gallium modulates osteoclastic bone resorption in vitro without affecting osteoblasts.Oral bisphosphonates and risk of cancer of oesophagus, stomach, and colorectum: case-control analysis within a UK primary care cohort.Osteoporosis therapies: evidence from health-care databases and observational population studies.Once-monthly risedronate for postmenopausal osteoporosisManagement of osteoporosis in patients hospitalized for hip fracturesBisphosphonate treatment and risk of esophageal cancer: a meta-analysis of observational studies.Zoledronic acid infusion for prevention and treatment of osteoporosisOral bisphosphonate compliance and persistence: a matter of choice?Long-term efficacy, safety, and patient acceptability of ibandronate in the treatment of postmenopausal osteoporosisIf you don't take it - it can't work: the consequences of not being treated or nonadherence to osteoporosis therapy.Patterns of anti-osteoporosis medication use among women at high risk of fracture: findings from the Global Longitudinal Study of Osteoporosis in Women (GLOW).Teriparatide treatment patterns in osteoporosis and subsequent fracture events: a US claims analysisOsteoporosis: New-Generation Drugs.The impact of pharmacist interventions on osteoporosis management: a systematic review.Factors Associated with Persistence with Teriparatide Therapy: Results from the DANCE Observational StudyOsteosynthetic improvement of osteoporotic bone: prevention surgery.Encounter Decision Aid vs. Clinical Decision Support or Usual Care to Support Patient-Centered Treatment Decisions in Osteoporosis: The Osteoporosis Choice Randomized Trial II.Validation of the adherence evaluation of osteoporosis treatment (ADEOS) questionnaire for osteoporotic post-menopausal women.Early (1-year) Discontinuation of Different Anti-osteoporosis Medications Compared: A Population-Based Cohort Study.Severe polyarthritis secondary to zolendronic acid: a case report and literature reviewLong-term persistence with anti-osteoporosis drugs after fracture.Bisphosphonate prescribing, persistence and cumulative exposure in Ontario, CanadaRelative effectiveness of osteoporosis drugs for preventing nonvertebral fracture.Clinical utility of risedronate in postmenopausal osteoporosis: patient considerations with delayed-release formulationThe impact of preventive measures on the burden of femoral fractures - a modelling approach to estimating the impact of fall prevention exercises and oral bisphosphonate treatment for the years 2014 and 2025
P2860
Q28384121-05278F6F-B550-4075-A3D5-0B136DB3CCC0Q30492459-A27E2F27-8029-420A-AF63-0A5D01B706EDQ30863128-94D3E5B3-3076-4289-933E-FDE4DAD3B20EQ30988951-05FECE83-AAB8-4BE1-B55A-F6BBA4586EF1Q33300458-2810FF64-DB48-459A-A3F7-DC316D147EE9Q33482035-A8C61210-1AB6-499C-A4C7-2D48D6F07AB6Q33610273-3454580E-2FA8-4E3C-9A6B-95D50E277C88Q33716678-FBE1A81C-8A04-4C55-948C-F07B65140E34Q33822430-71EFF422-25E3-4A24-A676-097F7DAE80A7Q33886852-C868A030-FAFC-4AD4-9128-6EF61F9AB44DQ34041189-678E95BF-F88D-48BD-9C6F-F9E515DD70DCQ34042003-D72E6000-FEEB-4F9E-9CCC-11A25166D862Q34070998-0F5228B3-5CA2-473D-8D34-499ADE506569Q34073740-F784CD81-5475-436C-8165-A8E5F7773826Q34075211-4C6D2BBC-0745-4258-9FB1-C4782F26EAD8Q34078767-57F22024-3C2C-407D-A489-EF8BB1CFCCB0Q34104102-A7A27102-6218-44D7-951C-F5A174052F8EQ34242906-8F363883-765E-4241-83EE-7A350960337BQ34272000-1F22E8FD-726F-4915-8AC5-84C542D5F949Q34284002-23D6D393-36BE-4ED7-9190-550D168AB746Q34305113-10D5D891-CFF4-45E6-B589-4DAA3AC265CEQ34345697-38D71857-27D4-43F5-BC0D-8F3FD3E603E6Q34472700-B7AE84AA-5E2B-4C35-AB8C-A26ABDDDEF90Q34758140-47F11304-EC41-43A1-A61C-20EB93DE5E07Q35050249-3DA51291-B42A-40E9-964F-9E89D3050265Q35077750-D96B4D1E-C213-48E5-A62C-9806BE861CB4Q35092617-946101FA-30CE-4939-AB56-C11085ADAE6AQ35095553-4A8DB022-5789-48D6-AB8C-C77FFCBE5DDDQ35204774-85D61C6D-EA83-4AA6-828C-E23827D638EAQ35371081-1576C8C2-7FC0-420D-AFCB-958F3F5F1ADAQ35593305-F6174209-EC9F-4EE0-88A5-11B75AD91D37Q35641529-083B0672-870B-4A33-9310-401AF3BCC864Q35681132-9D23E3D2-9183-48C2-933A-8658DA5BEB39Q35707347-E2286841-8666-44A5-8C8C-0FD75C5641AEQ35747575-CC3275EC-995F-4323-95CB-AF2634692AB6Q35747751-40688C69-41B0-471C-A272-0C14220E43A6Q35751437-4A2D4EA4-A845-4F2D-BC03-8D337A2C2580Q35774970-6CD8D48F-2404-45E7-BB6B-26FB13E4D326Q35905973-DC85FC2E-6DBE-46B7-89D1-FED14116E1C2Q35977780-892D90B5-8658-4C80-B2B2-7E78F8A52134
P2860
A systematic review of persistence and compliance with bisphosphonates for osteoporosis.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
A systematic review of persistence and compliance with bisphosphonates for osteoporosis.
@ast
A systematic review of persistence and compliance with bisphosphonates for osteoporosis.
@en
type
label
A systematic review of persistence and compliance with bisphosphonates for osteoporosis.
@ast
A systematic review of persistence and compliance with bisphosphonates for osteoporosis.
@en
prefLabel
A systematic review of persistence and compliance with bisphosphonates for osteoporosis.
@ast
A systematic review of persistence and compliance with bisphosphonates for osteoporosis.
@en
P2093
P1476
A systematic review of persistence and compliance with bisphosphonates for osteoporosis.
@en
P2093
Lewiecki EM
Silverman SL
P2888
P304
P356
10.1007/S00198-006-0322-8
P407
P577
2007-02-17T00:00:00Z